Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CLPT
RLMD
Add up to 3 more stocks
CLPT
ClearPoint Neuro, Inc.
-4.43%
$11.01-0.51Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$330.19M
52W Range
$8.27 - $30.10
RLMD
Relmada Therapeutics, Inc.
-5.75%
$3.28-0.20Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$344.04M
52W Range
$1.80 - $8.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 30.64 | 1.67 |
| P/S Ratio | 7.81 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 62.6% | 0.0% |
| Operating Margin | -65.4% | 0.0% |
| Net Margin | -81.8% | 0.0% |
| ROE | -320.8% | -30.0% |
| ROA | -39.9% | -28.3% |
| ROIC | -40.5% | -30.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.73 | 29.52 |
| Quick Ratio | 3.87 | 29.52 |
| Debt/Equity | 5.93 | 0.00 |
| Interest Coverage | -10.12 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.